BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 38483660)

  • 1. A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling.
    Fang F; Ooka K; Sun X; Shah R; Bhattacharyya S; Wei J; Varga J
    J Immunol; 2013 Sep; 191(6):2956-66. PubMed ID: 23956427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Toll-like receptor 3 inhibits HIV infection of human iPSC-derived microglia.
    Wang P; Liu JB; Wang X; Meng FZ; Xiao QH; Liu L; Zhu J; Hu WH; Ho WZ
    J Med Virol; 2023 Nov; 95(11):e29217. PubMed ID: 37933090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM2 suppresses TLR3-mediated IFN-β/ISG56/CXCL10 expression in BEAS-2B bronchial epithelial cells.
    Kobori Y; Tachizaki M; Imaizumi T; Tanaka Y; Seya K; Miki Y; Kawaguchi S; Matsumiya T; Tobisawa Y; Ohyama C; Tasaka S
    Mol Biol Rep; 2024 Mar; 51(1):417. PubMed ID: 38483660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISG56 is involved in CXCL10 expression induced by TLR3 signaling in BEAS-2B bronchial epithelial cells.
    Shiratori T; Imaizumi T; Hirono K; Kawaguchi S; Matsumiya T; Seya K; Tasaka S
    Exp Lung Res; 2020; 46(6):195-202. PubMed ID: 32363951
    [No Abstract]   [Full Text] [Related]  

  • 5. Toll-like receptor 3 signaling induces interferon-induced transmembrane protein 1 in BEAS-2B cells.
    Dobashi M; Shiratori T; Imaizumi T; Hashimoto S; Kawaguchi S; Seya K; Tasaka S
    Exp Biol Med (Maywood); 2022 Nov; 247(21):1917-1922. PubMed ID: 36112878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between interferon-stimulated gene 56 and melanoma differentiation-associated gene 5 in Toll-like receptor 3 signaling in normal human mesangial cells.
    Imaizumi T; Aizawa-Yashiro T; Matsumiya T; Yoshida H; Watanabe S; Tsuruga K; Tatsuta T; Xing F; Hayakari R; Meng P; Tanaka H
    Am J Nephrol; 2013; 37(2):118-25. PubMed ID: 23363937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISG54 and ISG56 are induced by TLR3 signaling in U373MG human astrocytoma cells: possible involvement in CXCL10 expression.
    Imaizumi T; Numata A; Yano C; Yoshida H; Meng P; Hayakari R; Xing F; Wang L; Matsumiya T; Tanji K; Tatsuta T; Murakami M; Tanaka H
    Neurosci Res; 2014 Jul; 84():34-42. PubMed ID: 24630834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-stimulated gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3/IFN-β/STAT1 axis in U373MG human astrocytoma cells.
    Imaizumi T; Yoshida H; Hayakari R; Xing F; Wang L; Matsumiya T; Tanji K; Kawaguchi S; Murakami M; Tanaka H
    Neurosci Res; 2016 Apr; 105():35-41. PubMed ID: 26423178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression.
    Sato S; Miyazaki M; Fukuda S; Mizutani Y; Mizukami Y; Higashiyama S; Inoue S
    J Biol Chem; 2023 Jun; 299(6):104826. PubMed ID: 37196767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMEM2 expression is downregulated as bladder cancer invades the muscle layer.
    Yoneyama MS; Yoneyama T; Tobisawa Y; Yamamoto H; Hatakeyama S; Yoneyama T; Hashimoto Y; Suzuki T; Ohyama C
    Biochem Biophys Res Commun; 2022 Jul; 613():1-6. PubMed ID: 35525055
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Jiang Q; Wang X; Yang Q; Zhang H; Wang X
    DNA Cell Biol; 2021 Nov; 40(11):1381-1395. PubMed ID: 34735293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.
    Bugide S; Gupta R; Green MR; Wajapeyee N
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM2 binds to CSNK2A3 to inhibit HBV infection via activation of the JAK/STAT pathway.
    Zhou H; Jia X; Hu K; Mo Z; Xu W; Peng L; Wang K; Zhu X
    Exp Cell Res; 2021 Mar; 400(1):112517. PubMed ID: 33582094
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.